AI assistant
Sending…
Annovis Bio, Inc. — Director's Dealing 2021
Aug 23, 2021
34695_dirs_2021-08-23_89a57d49-12d0-455e-b7b7-8931bed5df03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2021-08-19
Reporting Person: McCarthy Reid (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-19 | Common Stock, $0.0001 par value | P | 500 | $37.61 | Acquired | 6829 | Direct |
More from Annovis Bio, Inc.
Capital/Financing Update
2026
May 20
Share Issue/Capital Change
2026
May 20
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Capital/Financing Update
2026
Apr 9
Board/Management Information
2026
Mar 25
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Jan 28
Director's Dealing
2025
Dec 8